Naftin
- Product NDC
- 54766-772
- 11-digit product format
- 547660772
- Labeler code
- 54766
- Product ID
- 54766-772_43150f38-df38-5e12-e063-6294a90a1128
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naftifine Hydrochloride
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- Sebela Pharmaceuticals Inc.
- Application
- NDA204286
- Marketing category
- NDA
- Marketing start
- 2018-03-01
- Marketing end
- 2026-10-31
- Substance
- NAFTIFINE HYDROCHLORIDE
- Active strength
- 2 g/100g
- Pharmacologic classes
- Allylamine Antifungal [EPC], Allylamine [CS]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Naftin
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NAFTIFINE HYDROCHLORIDE | 2 g/100g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 25UR9N9041 |
| Rxcui | 1433734, 1433736 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 54766-772 | NAFTIN (NAFTIFINE HYDROCHLORIDE) GEL [SEBELA PHARMACEUTICALS INC.] | 5 | Current NDC, Legacy NDC, 4 package rows | 20231213_6645994a-ecb3-277b-e053-2a91aa0a81e5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 54766-772-45 | 54766077245 | 1 TUBE in 1 CARTON (54766-772-45) / 45 g in 1 TUBE | 1 tube | 2018-03-01 | 2026-10-31 | No | No | Current |
| 54766-772-60 | 54766077260 | 1 TUBE in 1 CARTON (54766-772-60) / 60 g in 1 TUBE | 1 tube | 2018-03-01 | 2026-10-31 | No | No | Current |